XML 57 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Statements (Details 4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Sources (uses) of cash and cash equivalents    
Net cash used in operating activities $ (27,631) $ (21,207)
Investing activities:    
Capital expenditures (15,481) (13,101)
Change in restricted cash 1,591  
Net cash used in investing activities (13,890) (13,101)
Financing activities:    
Deferred acquisition payments (1,204) (1,439)
Proceeds from issuance of debt   15,825
Payments of long-term debt (306) (1,576)
Proceeds from exercise of stock options 19 41
Debt issuance costs   (275)
Net cash provided by (used in) financing activities (1,491) 12,576
Net decrease in cash and cash equivalents (43,012) (21,732)
Effect of foreign currency fluctuations on cash 189 (943)
Cash and cash equivalents at beginning of fiscal period 95,978 210,521
Cash and cash equivalents at end of fiscal period 53,155 187,846
Parent
   
Sources (uses) of cash and cash equivalents    
Net cash used in operating activities (7,889) (14,653)
Financing activities:    
Deferred acquisition payments (204) (439)
Proceeds from issuance of debt   15,825
Payments of long-term debt (306)  
Proceeds from exercise of stock options 19 41
Debt issuance costs   (275)
Net cash provided by (used in) financing activities (491) 15,152
Net decrease in cash and cash equivalents (8,380) 499
Cash and cash equivalents at beginning of fiscal period 17,202 7,933
Cash and cash equivalents at end of fiscal period 8,822 8,432
Guarantor Subsidiaries
   
Sources (uses) of cash and cash equivalents    
Net cash used in operating activities (19,373) (15,306)
Investing activities:    
Capital expenditures (7,186) (3,660)
Change in restricted cash 1,591  
Net cash used in investing activities (5,595) (3,660)
Financing activities:    
Deferred acquisition payments (1,000) (1,000)
Net cash provided by (used in) financing activities (1,000) (1,000)
Net decrease in cash and cash equivalents (25,968) (19,966)
Cash and cash equivalents at beginning of fiscal period 52,056 178,205
Cash and cash equivalents at end of fiscal period 26,088 158,239
Non-Guarantor Subsidiaries
   
Sources (uses) of cash and cash equivalents    
Net cash used in operating activities (369) 8,752
Investing activities:    
Capital expenditures (8,295) (9,441)
Net cash used in investing activities (8,295) (9,441)
Financing activities:    
Payments of long-term debt   (1,576)
Net cash provided by (used in) financing activities   (1,576)
Net decrease in cash and cash equivalents (8,664) (2,265)
Effect of foreign currency fluctuations on cash 189 (943)
Cash and cash equivalents at beginning of fiscal period 26,720 24,383
Cash and cash equivalents at end of fiscal period $ 18,245 $ 21,175